menu
    • menu

    Company profile for BioCardia

    NEW Drugs in Dev: 12
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a clinical-stage regenerative medicine company with a mission, to bring to market comprehensive cell therapy solutions for the treatment of cardiovascular diseases with large unmet medical needs. Our Pipeline: Our lead therapeutic candidate is the investigational CardiAMP™ Cell Therapy System, which provides an autologous bone marrow derived cell therapy (using a patient's own cells) for the treatment of two clinic...
    We are a clinical-stage regenerative medicine company with a mission, to bring to market comprehensive cell therapy solutions for the treatment of cardiovascular diseases with large unmet medical needs. Our Pipeline: Our lead therapeutic candidate is the investigational CardiAMP™ Cell Therapy System, which provides an autologous bone marrow derived cell therapy (using a patient's own cells) for the treatment of two clinical indications - heart failure that develops after a heart attack and chronic myocardial ischemia.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BioCardiaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    125 Shoreway Road, SuiteB San Carlos, CA
    Telephone
    Telephone
    (800) 624-1179
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.biocardia.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ICMD China

    ICMD China

    Not Confirmed

    envelop Contact Supplier

    ICMD China

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BioCardia Files Request for Meeting With FDA to for CardiAMP
    BioCardia Files Request for Meeting With FDA to for CardiAMP

    02 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/02/3267485/0/en/BioCardia-Files-Request-for-Meeting-With-FDA-to-Discuss-Accelerated-Approval-Pathway-for-CardiAMP-System-in-Ischemic-Heart-Failure.html

    GLOBENEWSWIRE
    02 Apr 2026
    Share Share
    Biocardia Reports 2025 Business Highlights And Financial Results
    Biocardia Reports 2025 Business Highlights And Financial Results

    24 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/24/3261730/0/en/BioCardia-Reports-2025-Business-Highlights-and-Financial-Results.html

    GLOBENEWSWIRE
    24 Mar 2026
    Share Share
    Biocardia's Helix Catheter Pre-Submission Approved By FDA
    Biocardia's Helix Catheter Pre-Submission Approved By FDA

    17 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/17/3256943/0/en/BioCardia-Announces-Pre-Submission-Approval-Package-for-Helix-Transendocardial-Delivery-Catheter-Accepted-by-FDA.html

    GLOBENEWSWIRE
    17 Mar 2026
    Share Share
    Biocardia Presents CardiAMP HF Trial Echocardiography Results
    Biocardia Presents CardiAMP HF Trial Echocardiography Results

    03 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/03/3248292/0/en/BioCardia-Late-Breaking-Echocardiography-Clinical-Results-from-CardiAMP-HF-Trial-Presented-at-Technology-and-Heart-Failure-Therapeutics-THT.html

    GLOBENEWSWIRE
    03 Mar 2026
    Share Share
    BioCardia Files Pre-FDA Submission for Helix Heart Catheter
    BioCardia Files Pre-FDA Submission for Helix Heart Catheter

    10 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/10/3235432/0/en/BioCardia-Files-Pre-Submission-for-FDA-Approval-of-Helix-Transendocardial-Delivery-Catheter-for-Therapeutic-and-Diagnostic-Agent-Delivery-to-the-Heart.html

    GLOBENEWSWIRE
    10 Feb 2026
    Share Share
    Biocardia Unveils Cardiamp HF Trial Echocardiography Results
    Biocardia Unveils Cardiamp HF Trial Echocardiography Results

    03 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/03/3231040/0/en/BioCardia-Announces-Late-Breaking-Echocardiography-Results-from-the-CardiAMP-HF-Trial-to-be-Presented-at-Technology-and-Heart-Failure-Therapeutics-THT.html

    GLOBENEWSWIRE
    03 Feb 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search